à rédigé 231 articles
TWB published its 2015 activity report. The results confirm the attractiveness and the effectiveness of the mode of operation of TWB and of its associated research teams. Welcome of 10 new partners , entry into service of a unique microbial culture robotic platform…
Lire la suite
For the meeting of the Strategic Steering Committee on February 3 & 4, 2016, TWB welcomed the 7 new industrial partners of its consortium. These members noticed that TWB moved into a new phase of achievements when presenting the 2015 results…
Lire la suite
The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Pierre Monsan, Ph.D., Founding Director of TWB, to its College of Fellows. Dr. Monsan was nominated, reviewed, and elected by peers and members of the College of Fellows for outstanding scientific and industrial contributions to…
Lire la suite
Within the framework of a R&D contract between TWB and AMOEBA , TWB teams have been able to optimize amoeba production, by knocking down major technological barriers: transposing the process from an adhesion culture to a continuous suspension culture, multiplying by 10 the final amoeba concentration, developing a stable…
Lire la suite
TWB wishes you a happy holiday season and gives you appointment in 2016 with new developments and collaborations. Best wishes and See you soon! …
Lire la suite
TWB has announced the creation of EnobraQ, a company that develops yeast capable of using CO2 (atmospheric or of other origins) and transforming it into molecules of interest for the chemical industry. This company, installed at the TWB laboratories, is the product of a TWB research project. Sofinnova Partners, one…
Lire la suite
David Guerrand has joined TWB on September 1st, in charge of industry partnerships. David will work together with Michel Manach, Director of industry partnerships. This new resource will allow TWB to serve its development with a growing number of competitive contracts and industry partners joining TWB.
Lire la suite
TWB provides financial support to the iGEM Toulouse 2015 team. The aim of the project is the development of a means of controlling Varroa, the first cause of parasite-induced mortality among honey bees in Europe and in the US, by using a biological pathway that is more…
Lire la suite
TWB and Hamilton have collaborated for 18 months to develop an innovative bioprocessing platform for the in-depth characterization and culture optimization of microorganisms. This platform, with 24 integrated mini-bioreactors (50 mL), will significantly speed up the process to develop industrial bioprocess solutions for a wide range of…
Lire la suite